201 related articles for article (PubMed ID: 33763999)
1. Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance.
Ward SE; O'Sullivan JM; Moran AB; Spencer DIR; Gardner RA; Sharma J; Fazavana J; Monopoli M; McKinnon TAJ; Chion A; Haberichter S; O'Donnell JS
Haematologica; 2022 Mar; 107(3):668-679. PubMed ID: 33763999
[TBL] [Abstract][Full Text] [Related]
2. A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance.
Ward SE; O'Sullivan JM; Drakeford C; Aguila S; Jondle CN; Sharma J; Fallon PG; Brophy TM; Preston RJS; Smyth P; Sheils O; Chion A; O'Donnell JS
Blood; 2018 Feb; 131(8):911-916. PubMed ID: 29282218
[TBL] [Abstract][Full Text] [Related]
3. N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor.
O'Sullivan JM; Aguila S; McRae E; Ward SE; Rawley O; Fallon PG; Brophy TM; Preston RJ; Brady L; Sheils O; Chion A; O'Donnell JS
J Thromb Haemost; 2016 Dec; 14(12):2446-2457. PubMed ID: 27732771
[TBL] [Abstract][Full Text] [Related]
4. N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance.
Chion A; O'Sullivan JM; Drakeford C; Bergsson G; Dalton N; Aguila S; Ward S; Fallon PG; Brophy TM; Preston RJ; Brady L; Sheils O; Laffan M; McKinnon TA; O'Donnell JS
Blood; 2016 Oct; 128(15):1959-1968. PubMed ID: 27554083
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor sialylation-A critical regulator of biological function.
Ward S; O'Sullivan JM; O'Donnell JS
J Thromb Haemost; 2019 Jul; 17(7):1018-1029. PubMed ID: 31055873
[TBL] [Abstract][Full Text] [Related]
6. Macrophage Galactose Lectin Contributes to the Regulation of FVIII (Factor VIII) Clearance in Mice-Brief Report.
Ward SE; Guest T; Byrne C; Lopes P; O'Sullivan JM; Doherty D; O'Connell D; Gutierrez Llaneza S; Chion A; Fazavana J; Fallon PG; Preston RJS; Johnsen JM; Pipe SW; Turecek PL; O'Donnell JS;
Arterioscler Thromb Vasc Biol; 2023 Apr; 43(4):540-546. PubMed ID: 36727518
[TBL] [Abstract][Full Text] [Related]
7. Increased galactose expression and enhanced clearance in patients with low von Willebrand factor.
Aguila S; Lavin M; Dalton N; Patmore S; Chion A; Trahan GD; Jones KL; Keenan C; Brophy TM; O'Connell NM; Ryan K; Byrne M; Nolan M; Patel A; Preston RJS; James P; Di Paola J; O'Sullivan JM; O'Donnell JS
Blood; 2019 Apr; 133(14):1585-1596. PubMed ID: 30770394
[TBL] [Abstract][Full Text] [Related]
8. Investigating the clearance of VWF A-domains using site-directed PEGylation and novel N-linked glycosylation.
Fazavana J; Brophy TM; Chion A; Cooke N; Terraube V; Cohen J; Parng C; Pittman D; Cunningham O; Lambert M; O'Donnell JS; O'Sullivan JM
J Thromb Haemost; 2020 Jun; 18(6):1278-1290. PubMed ID: 32108991
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor clearance - biological mechanisms and clinical significance.
O'Sullivan JM; Ward S; Lavin M; O'Donnell JS
Br J Haematol; 2018 Oct; 183(2):185-195. PubMed ID: 30378120
[TBL] [Abstract][Full Text] [Related]
10. Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance.
Wohner N; Legendre P; Casari C; Christophe OD; Lenting PJ; Denis CV
J Thromb Haemost; 2015 May; 13(5):815-20. PubMed ID: 25728415
[TBL] [Abstract][Full Text] [Related]
11. An Insight into Glyco-Microheterogeneity of Plasma von Willebrand Factor by Mass Spectrometry.
Gashash EA; Aloor A; Li D; Zhu H; Xu XQ; Xiao C; Zhang J; Parameswaran A; Song J; Ma C; Xiao W; Wang PG
J Proteome Res; 2017 Sep; 16(9):3348-3362. PubMed ID: 28696719
[TBL] [Abstract][Full Text] [Related]
12. Platelet GpIba binding to von Willebrand Factor under fluid shear:contributions of the D′D3-domain, A1-domain flanking peptide and O-linked glycans.
Madabhushi SR; Zhang C; Kelkar A; Dayananda KM; Neelamegham S
J Am Heart Assoc; 2014 Oct; 3(5):e001420. PubMed ID: 25341886
[TBL] [Abstract][Full Text] [Related]
13. Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13.
McGrath RT; McKinnon TA; Byrne B; O'Kennedy R; Terraube V; McRae E; Preston RJ; Laffan MA; O'Donnell JS
Blood; 2010 Apr; 115(13):2666-73. PubMed ID: 19965639
[TBL] [Abstract][Full Text] [Related]
14. Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue.
Riswari SF; Tunjungputri RN; Kullaya V; Garishah FM; Utari GSR; Farhanah N; Overheul GJ; Alisjahbana B; Gasem MH; Urbanus RT; de Groot PG; Lefeber DJ; van Rij RP; van der Ven A; de Mast Q
PLoS Pathog; 2019 Mar; 15(3):e1007500. PubMed ID: 30849118
[TBL] [Abstract][Full Text] [Related]
15. Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels.
van Schooten CJ; Denis CV; Lisman T; Eikenboom JC; Leebeek FW; Goudemand J; Fressinaud E; van den Berg HM; de Groot PG; Lenting PJ
Blood; 2007 Mar; 109(6):2430-7. PubMed ID: 17090649
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor arginine 1205 substitution results in accelerated macrophage-dependent clearance in vivo.
Rawley O; O'Sullivan JM; Chion A; Keyes S; Lavin M; van Rooijen N; Brophy TM; Fallon P; Preston RJ; O'Donnell JS
J Thromb Haemost; 2015 May; 13(5):821-6. PubMed ID: 25690668
[TBL] [Abstract][Full Text] [Related]
17. O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies.
Karampini E; Doherty D; Bürgisser PE; Garre M; Schoen I; Elliott S; Bierings R; O'Donnell JS
Blood Adv; 2024 Jun; 8(12):3254-3266. PubMed ID: 38640438
[TBL] [Abstract][Full Text] [Related]
18. The physical spacing between the von Willebrand factor D'D3 and A1 domains regulates platelet adhesion in vitro and in vivo.
Zhang C; Kelkar A; Nasirikenari M; Lau JTY; Sveinsson M; Sharma UC; Pokharel S; Neelamegham S
J Thromb Haemost; 2018 Mar; 16(3):571-582. PubMed ID: 29251812
[TBL] [Abstract][Full Text] [Related]
19. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
Martin C; Morales LD; Cruz MA
J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
[TBL] [Abstract][Full Text] [Related]
20. Desialylation of O-glycans activates von Willebrand factor by destabilizing its autoinhibitory module.
Voos KM; Cao W; Arce NA; Legan ER; Wang Y; Shajahan A; Azadi P; Lollar P; Zhang XF; Li R
J Thromb Haemost; 2022 Jan; 20(1):196-207. PubMed ID: 34529349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
